WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010139481) GLYCINE B ANTAGONISTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/139481    International Application No.:    PCT/EP2010/003383
Publication Date: 09.12.2010 International Filing Date: 04.06.2010
IPC:
C07C 65/21 (2006.01), C07C 235/24 (2006.01), C07C 235/68 (2006.01), C07C 311/51 (2006.01), A61K 31/167 (2006.01), A61P 25/02 (2006.01)
Applicants: MERZ PHARMA GMBH & CO. KGAA [DE/DE]; Eckenheimer Landstraße 100 60318 Frankfurt am Main (DE) (For All Designated States Except US).
HENRICH, Markus [DE/DE]; (DE) (For US Only).
BAUER, Angela [DE/DE]; (DE) (For US Only).
NAGEL, Jens [DE/DE]; (DE) (For US Only).
KAUSS, Valerjans [LV/LV]; (LV) (For US Only).
TRIFANOVA, Dina [LV/LV]; (LV) (For US Only).
GRUNSTEINE, Ginta [LV/LV]; (LV) (For US Only).
ROZHKOVS, Jevgenijs [LV/LV]; (LV) (For US Only)
Inventors: HENRICH, Markus; (DE).
BAUER, Angela; (DE).
NAGEL, Jens; (DE).
KAUSS, Valerjans; (LV).
TRIFANOVA, Dina; (LV).
GRUNSTEINE, Ginta; (LV).
ROZHKOVS, Jevgenijs; (LV)
Agent: DEHNS; St. Bride's House 10 Salisbury Square London EC4Y 8JD (GB)
Priority Data:
09007401.4 04.06.2009 EP
61/217,777 04.06.2009 US
Title (EN) GLYCINE B ANTAGONISTS
(FR) ANTAGONISTES DE LA GLYCINE B
Abstract: front page image
(EN)The invention relates to naphthalene derivatives as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are glycine B antagonists and are therefore useful for the control and prevention of various disorders, including neurological disorders.
(FR)La présente invention a pour objet des dérivés du naphtalène ainsi que leurs sels pharmaceutiquement acceptables. L'invention concerne en outre un procédé pour la préparation de ces composés. Les composés de l'invention sont des antagonistes de la glycine B et sont par conséquent utiles pour la maîtrise et la prévention de différents troubles, comprenant les troubles neurologiques.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)